Preclinical Pharmacokinetic Analysis of NOV-002, a Glutathione Disulfide Mimetic

NOV-002 is a glutathione disulfide (GSSG) mimetic that is in Phase III clinical trials for the treatment of advanced non-small cell lung cancer and other oncology indications. GSSG is reduced by glutathione reductase (GR) to form glutathione (GSH), thereby maintaining redox homeostasis. The purpose...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Uys, Joachim D., Manevich, Yefim, DeVane, Lindsay C., He, Lin, Garret, Tracy E., Pazoles, Christopher J., Tew, Kenneth D., Townsend, Danyelle M.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2921589/
https://ncbi.nlm.nih.gov/pubmed/20359856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2010.01.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares